Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

A rare case of childhood-onset systemic lupus erythematosus associated end-stage renal disease with cerebral abscess and hemorrhage

  • Jee Hyun Kim (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Jae Il Shin (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Ji Hong Kim (Department of Pediatrics, Yonsei University College of Medicine) ;
  • Keum Hwa Lee (Department of Pediatrics, Yonsei University College of Medicine)
  • Received : 2024.01.12
  • Accepted : 2024.02.14
  • Published : 2024.02.28
Download PDF
⟨ Previous Next ⟩

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease that affects multiple organs. More than half of the patients with SLE have kidney involvement, and up to 10% of patients with lupus nephritis develop end-stage renal disease (ESRD). Central nervous system (CNS) involvement in SLE occurs in 21% to 95% of patients. Severe neurological manifestations such as seizures, cerebrovascular disease, meningitis, and cerebrovascular accidents can develop in childhood-onset SLE, but cerebral infections, such as brain abscess and hemorrhage, are seldom reported in lupus nephritis, even in adults. Here, we report a rare case of childhood-onset SLE with ESRD, cerebral abscess, and hemorrhage. A 9-year-old girl diagnosed with lupus nephritis was administered high-dose steroids and immunosuppressant therapy to treat acute kidney injury (AKI) and massive proteinuria. The AKI deteriorated, and after 3 months, she developed ESRD. She received hemodialysis three times a week along with daily peritoneal dialysis to control edema. She developed seizures, and imaging showed a brain abscess. This was complicated by spontaneous cerebral hemorrhage, and she became unstable. She died shortly after the hemorrhage was discovered. In conclusion, CNS complications should always be considered in clinical practice because they increase mortality, especially in those with risk factors for infection.

Keywords

References

  1. Sinha R, Raut S. Pediatric lupus nephritis: management update. World J Nephrol 2014;3:16-23.  https://doi.org/10.5527/wjn.v3.i2.16
  2. Fatemi A, Matinfar M, Smiley A. Childhood versus adult-onset systemic lupus erythematosus: long-term outcome and predictors of mortality. Clin Rheumatol 2017;36:343-50.  https://doi.org/10.1007/s10067-016-3509-1
  3. Ambrose N, Morgan TA, Galloway J, Ionnoau Y, Beresford MW, Isenberg DA, et al. Differences in disease phenotype and severity in SLE across age groups. Lupus 2016;25:1542-50.  https://doi.org/10.1177/0961203316644333
  4. Levy DM, Kamphuis S. Systemic lupus erythematosus in children and adolescents. Pediatr Clin North Am 2012;59:345-64.  https://doi.org/10.1016/j.pcl.2012.03.007
  5. Bertsias GK, Boumpas DT. Connective tissue diseases: Lupus nephritis-winning a few battles but not the war. Nat Rev Rheumatol 2011;7:441-2.  https://doi.org/10.1038/nrrheum.2011.88
  6. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31:2156-62. 
  7. Manger K, Manger B, Repp R, Geisselbrecht M, Geiger A, Pfahlberg A, et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann Rheum Dis 2002;61:1065-70.  https://doi.org/10.1136/ard.61.12.1065
  8. Kittivisuit S, Vachvanichsanong P, McNeil E, Chotsampancharoen T. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: prevalence and risk factors. Pediatr Blood Cancer 2021;68:e29146. 
  9. Bennett M, Brunner HI. Biomarkers and updates on pediatrics lupus nephritis. Rheum Dis Clin North Am 2013;39:833-53.  https://doi.org/10.1016/j.rdc.2013.05.001
  10. Pereira T, Abitbol CL, Seeherunvong W, Katsoufis C, Chandar J, Freundlich M, et al. Three decades of progress in treating childhood-onset lupus nephritis. Clin J Am Soc Nephrol 2011;6:2192-9.  https://doi.org/10.2215/CJN.00910111
  11. Hiraki LT, Lu B, Alexander SR, Shaykevich T, Alarcon GS, Solomon DH, et al. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum 2011;63:1988-97.  https://doi.org/10.1002/art.30350
  12. Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum 2009;61:13-20.  https://doi.org/10.1002/art.24091
  13. Doria A, Arienti S, Rampudda M, Canova M, Tonon M, Sarzi-Puttini P. Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 2008;7:192-7.  https://doi.org/10.1016/j.autrev.2007.11.004
  14. Poinen K, Quinn RR, Clarke A, Ravani P, Hiremath S, Miller LM, et al. Complications from tunneled hemodialysis catheters: a Canadian observational cohort study. Am J Kidney Dis 2019;73:467-75.  https://doi.org/10.1053/j.ajkd.2018.10.014
  15. Abbasi SH, Aftab RA, Chua SS. Risk factors associated with nosocomial infections among end stage renal disease patients undergoing hemodialysis: a systematic review. PLoS One 2020;15:e0234376.